We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
HPi2 antibody (HIC1-2B4.2B)
As low as
€480.40
In stock
Ref
00099054
Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.
| ID Covalab | mab50795 |
|---|---|
| Product type | Primary antibodies |
| Clonality | Monoclonal antibody |
| Clone | HIC1-2B4.2B |
| Isotype | IgG1 |
| Raised in | Mouse |
| Immunogen | Human pancreatic enriched islet cells containing low levels of exocrine and ductal cells. |
| Activity cross reaction | Reacts with human HPi2 protein (specific for multiple endocrine cell types) |
| Species | Hu |
| Labelling | None |
| Form | Cell culture supernatant |
| Preservative | NaN3 0.09% |
| Storage instructions | Store at 4°C. Do not freeze. |
| Target | HPi2 |
| Applications | FC, ICC, IF, IHC - F |
| Working dilutions | Optimal dilution should be determined by the end user. The following are guidelines only : - FC : 1/50 to 1/100 - IHC - F : 1/100 |
Write Your Own Review